Invivoscribe FLT3 Testing Patents Strengthened by Supreme Court Ruling
19. Juni 2013 08:36 ET
|
Invivoscribe Technologies, Inc.
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) - In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the...